| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 1996;28:22-30.)
© 1996 American Heart Association, Inc.
Articles |
Relationship Between Left Ventricular Geometry and Natriuretic Peptide Levels in Essential Hypertension
the Division of Hypertension and Nephrology (T.N., F.Y., A.M., K.I., T.I., T.O., H. Matsuoka) and Research Institute (Y.S., K.K., H. Matsuo), National Cardiovascular Center, Osaka, Japan.
Previous studies have shown that plasma levels of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are increased in essential hypertension. However, whether left ventricular geometry affects plasma ANP and BNP levels remains unknown. To investigate the effect of left ventricular geometry on plasma ANP and BNP levels in essential hypertension, we measured plasma ANP and BNP levels in 90 patients with essential hypertension. All patients were hospitalized, and fasting blood samples were obtained in the early morning after 30 minutes of bed rest. Plasma ANP and BNP levels were measured by immunoradiometric assay. Hypertensive patients were classified into four groups according to echocardiographic findings that showed normal geometry, concentric remodeling, eccentric hypertrophy, or concentric hypertrophy. Mean plasma ANP and BNP levels in all essential hypertensive patients were higher than those in age-matched normotensive control subjects. Plasma ANP levels in hypertensive patients with concentric remodeling, eccentric hypertrophy, and concentric hypertrophy were higher than in normotensive control subjects, although there were no differences between normotensive subjects and hypertensive patients with normal geometry. Plasma BNP levels tended to be higher in hypertensive patients with normal geometry, concentric remodeling, and eccentric hypertrophy than in normotensive control subjects; however, the differences were not significant. Plasma BNP levels and BNP/ANP ratio were specifically higher in concentric hypertrophy. There were significant correlations between ANP and left ventricular mass index, relative wall thickness, interventricular septal thickness, posterior wall thickness, and mean arterial pressure. Plasma BNP levels significantly correlated with relative wall thickness, interventricular septal thickness, posterior wall thickness, and left ventricular mass index but not with mean arterial pressure. In addition, plasma BNP levels were well correlated with ANP levels, and the slope for the linear regression model was steeper in concentric hypertrophy than in the other four groups. These results show that plasma ANP and BNP levels are increased in essential hypertensive patients with left ventricular hypertrophy. Furthermore, BNP secretion is augmented to a greater extent in concentric hypertrophy. Thus, measurement of plasma ANP and BNP levels may be useful for the detection of concentric left ventricular hypertrophy in patients with essential hypertension.
Key Words: hypertrophy • hypertension, essential • natriuretic peptides
This article has been cited by other articles:
 |
|
 |
|
  A. Biolo, S. Ramamurthy, L. H. Connors, C. J. O'Hara, H. K. Meier-Ewert, P. T. Soo Hoo, D. B. Sawyer, D. S. Seldin, and F. Sam Matrix Metalloproteinases and Their Tissue Inhibitors in Cardiac Amyloidosis: Relationship to Structural, Functional Myocardial Changes and to Light Chain Amyloid Deposition Circ Heart Fail, November 1, 2008; 1(4): 249 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Codognotto, A. Piccoli, M. Zaninotto, M. Mion, M. Plebani, U. Vertolli, F. Tona, L. Ruzza, A. Barchita, and G. M. Boffa Renal Dysfunction Is a Confounder for Plasma Natriuretic Peptides in Detecting Heart Dysfunction in Uremic and Idiopathic Dilated Cardiomyopathies Clin. Chem., December 1, 2007; 53(12): 2097 - 2104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tsutamoto, H. Sakai, C. Ishikawa, M. Fujii, T. Tanaka, T. Yamamoto, H. Takashima, M. Ohnishi, A. Wada, and M. Horie Direct comparison of transcardiac difference between brain natriuretic peptide (BNP) and N-terminal pro-BNP in patients with chronic heart failure Eur J Heart Fail, June 1, 2007; 9(6-7): 667 - 673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Wang, P. Gona, M. G. Larson, D. Levy, E. J. Benjamin, G. H. Tofler, P. F. Jacques, J. B. Meigs, N. Rifai, J. Selhub, et al. Multiple Biomarkers and the Risk of Incident Hypertension Hypertension, March 1, 2007; 49(3): 432 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Konstam Natriuretic Peptides and Cardiovascular Events: More Than a Stretch JAMA, January 10, 2007; 297(2): 212 - 214. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Belluardo, A. Cataliotti, L. Bonaiuto, E. Giuffre, E. Maugeri, P. Noto, G. Orlando, G. Raspa, B. Piazza, L. Babuin, et al. Lack of activation of molecular forms of the BNP system in human grade 1 hypertension and relationship to cardiac hypertrophy Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1529 - H1535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.v. Lukowicz, M. Fischer, H.W. Hense, A. Doring, J. Stritzke, G. Riegger, H. Schunkert, and A. Luchner BNP as a marker of diastolic dysfunction in the general population: Importance of left ventricular hypertrophy Eur J Heart Fail, June 1, 2005; 7(4): 525 - 531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Goetze, J. F. Rehfeld, R. Videbaek, L. Friis-Hansen, and J. Kastrup B-type natriuretic peptide and its precursor in cardiac venous blood from failing hearts Eur J Heart Fail, January 1, 2005; 7(1): 69 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Karagiannis, K. Tziomalos, and C. Zamboulis Plasma B-type natriuretic peptide is related to left ventricular mass in hypertensive patients Eur. Heart J., November 1, 2004; 25(21): 1967 - 1967. [Full Text] [PDF]
|
|
|
|
 |
|
 L. B. Yap, D. Mukerjee, P. M. Timms, H. Ashrafian, and J. G. Coghlan Natriuretic Peptides, Respiratory Disease, and the Right Heart Chest, October 1, 2004; 126(4): 1330 - 1336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Golbathy, O. Ucar, A. G. Yuksel, O. Gulel, S. Aydogdu, and V. Ulusoy Plasma brain natriuretic peptide levels in patients with rheumatic heart disease Eur J Heart Fail, October 1, 2004; 6(6): 757 - 760. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nishikimi, H. Matsuoka, W.H. W. Tang, R. C. Starling, J. B. Young, G. S. Francis, J. P. Girod, M. J. Lee, and F. Van Lente Plasma Brain Natriuretic Peptide Levels Indicate the Distance From Decompensated Heart Failure * Response Circulation, June 29, 2004; 109(25): e329 - e330. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Berendes, C. Schmidt, H. Van Aken, M. G. Hartlage, S. Wirtz, H. Reinecke, M. Rothenburger, H. H. Scheld, B. Schluter, G. Brodner, et al. Reversible Cardiac Sympathectomy by High Thoracic Epidural Anesthesia Improves Regional Left Ventricular Function in Patients Undergoing Coronary Artery Bypass Grafting: A Randomized Trial Arch Surg, December 1, 2003; 138(12): 1283 - 1290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J H Henriksen, J P Gotze, S Fuglsang, E Christensen, F Bendtsen, and S Moller Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease Gut, October 1, 2003; 52(10): 1511 - 1517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ruskoaho Cardiac Hormones as Diagnostic Tools in Heart Failure Endocr. Rev., June 1, 2003; 24(3): 341 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Fesler, G. du Cailar, J. Ribstein, and A. Mimran Left Ventricular Remodeling and Renal Function in Never-Treated Essential Hypertension J. Am. Soc. Nephrol., April 1, 2003; 14(4): 881 - 887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Freitag, M. G. Larson, D. Levy, E. J. Benjamin, T. J. Wang, E. P. Leip, P. W.F. Wilson, and R. S. Vasan Plasma Brain Natriuretic Peptide Levels and Blood Pressure Tracking in the Framingham Heart Study Hypertension, April 1, 2003; 41(4): 978 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tsuruda, G. Boerrigter, B. K. Huntley, J. A. Noser, A. Cataliotti, L. C. Costello-Boerrigter, H. H. Chen, and J. C. Burnett Jr Brain Natriuretic Peptide Is Produced in Cardiac Fibroblasts and Induces Matrix Metalloproteinases Circ. Res., December 13, 2002; 91(12): 1127 - 1134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hirata, A. Matsumoto, T. Aoyagi, K. Yamaoki, I. Komuro, T. Suzuki, T. Ashida, T. Sugiyama, Y. Hada, I. Kuwajima, et al. Measurement of plasma brain natriuretic peptide level as a guide for cardiac overload Cardiovasc Res, August 15, 2001; 51(3): 585 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. ZOCCALI, F. MALLAMACI, F. A. BENEDETTO, G. TRIPEPI, S. PARLONGO, A. CATALIOTTI, S. CUTRUPI, G. GIACONE, I. BELLANUOVA, E. COTTINI, et al. Cardiac Natriuretic Peptides Are Related to Left Ventricular Mass and Function and Predict Mortality in Dialysis Patients J. Am. Soc. Nephrol., July 1, 2001; 12(7): 1508 - 1515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A Sagnella Practical implications of current natriuretic peptide research Journal of Renin-Angiotensin-Aldosterone System, December 1, 2000; 1(4): 304 - 315. [PDF]
|
|
|
|
 |
|
 Y. Matsumoto, M. Hamada, and K. Hiwada Aortic Distensibility is Closely Related to the Progression of Left Ventricular Hypertrophy in Patients Receiving Hemodialysis Angiology, November 1, 2000; 51(11): 933 - 941. [Abstract] [PDF]
|
|
|
|
|
|
T. Nakayama, M. Soma, Y. Takahashi, D. Rehemudula, K. Kanmatsuse, and K. Furuya Functional Deletion Mutation of the 5'-Flanking Region of Type A Human Natriuretic Peptide Receptor Gene and Its Association With Essential Hypertension and Left Ventricular Hypertrophy in the Japanese Circ. Res., April 28, 2000; 86(8): 841 - 845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Dubois, I. Kishimoto, T. O. Lillis, and D. L. Garbers A genetic model defines the importance of the atrial natriuretic peptide receptor (guanylyl cyclase-A) in the regulation of kidney function PNAS, April 11, 2000; 97(8): 4369 - 4373. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Yoshihara, T. Nishikimi, Y. Sasako, J. Kobayashi, Y. Kosakai, R. Hattori, T. Horio, S. Kitamura, H. Matsuo, T. Ohe, et al. PRESERVATION OF THE RIGHT ATRIAL APPENDAGE IMPROVES REDUCED PLASMA ATRIAL NATRIURETIC PEPTIDE LEVELS AFTER THE MAZE PROCEDURE J. Thorac. Cardiovasc. Surg., April 1, 2000; 119(4): 790 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Talwar, A Siebenhofer, B Williams, and L Ng Influence of hypertension, left ventricular hypertrophy, and left ventricular systolic dysfunction on plasma N terminal proBNP Heart, March 1, 2000; 83(3): 278 - 282. [Abstract] [Full Text]
|
|
|
|
|
|
R. Pedrinelli, G. Dell'Omo, G. Penno, S. Bandinelli, A. Bertini, V. Di Bello, and M. Mariani Microalbuminuria and Pulse Pressure in Hypertensive and Atherosclerotic Men Hypertension, January 1, 2000; 35(1): 48 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. van der Zander, A. J.H.M Houben, A. A Kroon, and P. W de Leeuw Effects of brain natriuretic peptide on forearm vasculature: comparison with atrial natriuretic peptide Cardiovasc Res, December 1, 1999; 44(3): 595 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Matsuo, T. Nishikimi, C. Yutani, T. Kurita, W. Shimizu, A. Taguchi, K. Suyama, N. Aihara, S. Kamakura, K. Kangawa, et al. Diagnostic Value of Plasma Levels of Brain Natriuretic Peptide in Arrhythmogenic Right Ventricular Dysplasia Circulation, December 1, 1998; 98(22): 2433 - 2440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Yoshihara, T. Nishikimi, Y. Kosakai, F. Isobe, H. Matsuoka, S. Takishita, Y. Kawashima, Y. Saito, H. Matsuo, and K. Kangawa Atrial natriuretic peptide secretion and body fluid balance after bilateral atrial appendectomy by the maze procedure J. Thorac. Cardiovasc. Surg., August 1, 1998; 116(2): 213 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nishikimi, T. Horio, T. Sasaki, F. Yoshihara, S. Takishita, A. Miyata, H. Matsuo, and K. Kangawa Cardiac Production and Secretion of Adrenomedullin Are Increased in Heart Failure Hypertension, December 1, 1997; 30(6): 1369 - 1375. [Abstract] [Full Text]
|
|